Analysts’ updated eps estimates for Wednesday, September 2nd:
Apple (NASDAQ:AAPL) had its neutral rating reissued by analysts at DA Davidson. The firm currently has a $270.00 price target on the stock.
ACI Worldwide (NASDAQ:ACIW) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $66.00 price target on the stock.
American International Group (NYSE:AIG) had its buy rating reissued by analysts at Argus. The firm currently has a $90.00 target price on the stock.
Alumis (NASDAQ:ALMS) was upgraded by analysts at HC Wainwright from a neutral rating to a buy rating. They currently have $15.00 price target on the stock, down from their previous price target of $25.00.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $455.00 price target on the stock.
Amrize (NYSE:AMRZ) had its underperform rating reaffirmed by analysts at Bank of America Corporation. The firm currently has a $40.00 target price on the stock, down from their previous target price of $50.00.
Amrize (NYSE:AMRZ) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. The firm currently has $52.00 target price on the stock.
Ashtead Technology (LON:AT) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 650 target price on the stock.
Avon Protection (LON:AVON) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 2,390 price target on the stock.
AstraZeneca (LON:AZN) had its sell rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a £115 target price on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $120.00 target price on the stock.
Bunzl (LON:BNZL) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 3,000 target price on the stock.
Salesforce (NYSE:CRM) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $400.00 price target on the stock.
Salesforce (NYSE:CRM) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $300.00 target price on the stock.
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its neutral rating reiterated by analysts at Cantor Fitzgerald.
DCC (LON:DCC) was downgraded by analysts at Berenberg Bank to a hold rating. They currently have GBX 6,700 price target on the stock.
Ecora Resources (LON:ECOR) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 190 target price on the stock.
Ecora Resources (LON:ECOR) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 195 target price on the stock.
Eyepoint Pharmaceuticals (NASDAQ:EYPT) was downgraded by analysts at TD Cowen from a buy rating to a hold rating. They currently have $4.00 price target on the stock, down from their previous price target of $20.00.
GB Group (LON:GBG) was downgraded by analysts at Berenberg Bank to a hold rating. The firm currently has GBX 190 price target on the stock, down from their previous price target of GBX 260.
Guardant Health (NASDAQ:GH) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $195.00 price target on the stock.
Gresham House Energy Storage (LON:GRID) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc..
GSK (LON:GSK) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 2,000 price target on the stock.
GitLab (NASDAQ:GTLB) had its neutral rating reissued by analysts at Guggenheim.
Halozyme Therapeutics (NASDAQ:HALO) had its buy rating reissued by analysts at HC Wainwright. They currently have a $115.00 price target on the stock.
Intercontinental Hotels Group (NYSE:IHG) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. They currently have $188.00 target price on the stock.
ING Group (NYSE:ING) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.
Jack Henry & Associates (NASDAQ:JKHY) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $198.00 target price on the stock.
Kestra Medical Technologies (NASDAQ:KMTS) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $32.00 price target on the stock.
Knife River (NYSE:KNF) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. The firm currently has $73.00 target price on the stock.
Legal & General Group (LON:LGEN) had its underperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a GBX 270 target price on the stock.
Louisiana-Pacific (NYSE:LPX) had its buy rating reiterated by analysts at DA Davidson. The firm currently has a $99.00 price target on the stock.
Michelmersh Brick (LON:MBH) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 120 price target on the stock.
MongoDB (NASDAQ:MDB) had its buy rating reiterated by analysts at DA Davidson. The firm currently has a $465.00 target price on the stock.
MongoDB (NASDAQ:MDB) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $430.00 target price on the stock.
MongoDB (NASDAQ:MDB) had its market outperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $519.00 price target on the stock.
MongoDB (NASDAQ:MDB) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $560.00 target price on the stock.
Medtronic (NYSE:MDT) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $118.00 target price on the stock.
Martin Marietta Materials (NYSE:MLM) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $680.00 price target on the stock.
Modine Manufacturing (NYSE:MOD) had its overweight rating reaffirmed by analysts at KeyCorp. They currently have a $280.00 target price on the stock.
Motorpoint Group (LON:MOTR) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.
Matador Resources (NYSE:MTDR) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. They currently have $77.00 price target on the stock, down from their previous price target of $79.00.
Mitie Group (LON:MTO) was downgraded by analysts at Berenberg Bank to a hold rating. They currently have GBX 219 target price on the stock, down from their previous target price of GBX 230.
NIO (NYSE:NIO) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $4.50 price target on the stock.
NatWest Group (NYSE:NWG) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.
NatWest Group (LON:NWG) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 770 price target on the stock.
OSB Group (LON:OSB) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 720 price target on the stock.
Oxford Biomedica (LON:OXB) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 595 price target on the stock.
Paragon Banking Group (LON:PAG) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 1,070 price target on the stock.
Palo Alto Networks (NASDAQ:PANW) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $425.00 price target on the stock.
Palo Alto Networks (NASDAQ:PANW) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $425.00 price target on the stock.
Regent Gas Group (LON:RGG) had its house stock rating reiterated by analysts at Shore Capital Group Ltd. They currently have a GBX 120 price target on the stock.
Societe Generale Group (OTCMKTS:SCGLY) was downgraded by analysts at The Goldman Sachs Group, Inc. from a buy rating to a neutral rating.
Solaris Energy Infrastructure (NYSE:SEI) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $98.00 price target on the stock.
Smith & Nephew SNATS (NYSE:SNN) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating.
Telix Pharmaceuticals (NASDAQ:TLX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $20.00 price target on the stock.
TT Electronics (LON:TTG) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 110 target price on the stock.
Upstream Bio (NASDAQ:UPB) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $36.00 target price on the stock.
Vertu Motors (LON:VTU) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.
Karman Line Acquisition (NASDAQ:XTER) was upgraded by analysts at Wall Street Zen to a hold rating.
Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.
